Introduction {#S1}
============

Gambling disorder (GD) is associated with high rates of depression, substance-use disorders, and suicidality; as well as occupational and legal problems ([@B8]; [@B13]; [@B46]; [@B52]; [@B53]; [@B68]). The annual cost of GD is approximately 5 billion US dollars within the United States alone ([@B47]). Subsyndromal gambling is also a notable concern, and is defined as a significant gambling activity that does not meet full DSM-5 criteria for GD ([@B22]). Subsyndromal gamblers also show high rates of depression, anxiety disorders, substance-use disorders, financial, legal, family, and professional problems ([@B13]; [@B15]; [@B19]; [@B20]; [@B55]; [@B59]; [@B71]). Therefore, it is likely that gambling symptoms present on a continuum, and that symptoms should be assessed across the spectrum of gambling behavior ([@B13]; [@B17]; [@B19]; [@B22]; [@B58]; [@B59]; [@B62]; [@B68]; [@B71]).

The previous analyses have highlighted significant associations between GD/subsyndromal GD and increased rates of anxiety symptoms and anxiety disorders relative to the general population ([@B6]; [@B8]; [@B13]; [@B16]; [@B53]). One large epidemiological study found a lifetime prevalence of anxiety disorders of 41.3% among disordered gamblers ([@B53]). A systematic review of epidemiological studies corroborated these findings, with 37% of gamblers reporting a history of a comorbid anxiety disorder ([@B38]). In another analysis, Desai and Potenza ([@B16]) also found a high prevalence of panic disorder, generalized anxiety, and social phobia in subsyndromal GD.

Although anxiety symptoms are common in gamblers, less is known about how anxiety symptoms influence the clinical presentation of gambling problems. Various lines of research suggest that anxiety could be a powerful contributor to gambling behavior. First, the research in other addictions (alcohol-use disorder and substance-use disorder) suggests that the behavior may be a way to cope with anxiety ([@B61]). The relief of the anxiety, however, tends to be short-lived, and the symptoms may often reappear more intensely. As a result, a harmful cycle is created, and the anxious individual may therefore present with a more frequent and severe form of the addictive behavior. Second, attentional bias toward threatening elements is a well-characterized phenomenon in anxious individuals and, as a result of this, other non-threatening elements tend to be less perceived ([@B2]; [@B5]; [@B34]; [@B35]; [@B39]; [@B44]; [@B57]). Therefore, an anxious individual who gambles may have a reduced focus on the gambling behavior (i.e., how to bet and how much to bet). This attentional deficit may be another factor leading to a worse severity of GD. Finally, anxiety symptoms decrease some dimensions of quality of life ([@B64]). In this context, the increased emotional suffering and the lower level of life satisfaction could also increase the risk of suicide.

In light of this background, the objective of this study was to evaluate the association between anxiety symptoms, gambling activity, and neurocognition across the spectrum of gambling behavior (recreational gamblers, subsyndromal GD, and GD) in a non-treatment-seeking sample. We assessed the current severity of anxiety symptoms and associations between anxiety symptom severity, gambling symptoms, impulsiveness, and neurocognition. We predicted that anxiety symptoms would be associated with: (a) worse overall severity of GD, measured by increased gambling activity and more losses due to gambling and (b) higher impulsivity measured with clinical and neurocognitive tasks. In addition, we expected that anxiety would be correlated with: (c) worse clinical and neurocognitive attentional performance; (d) lower quality of life; and (e) higher levels of suicidality. If our hypotheses are correct, anxiety symptoms would be associated with variables correlated with poor prognosis and poor overall functioning. Therefore, proper management of anxiety should receive greater attention in clinical practice since it could improve the clinical presentation of gamblers in multiple domains. If our hypotheses are not supported, constant assessment and treatment of anxiety would be a secondary approach in the management of GD.

Methods {#S2}
=======

Sample {#S2a}
------

The sample consisted of 143 non-treatment-seeking young adults (aged 18--29 years) \[*n* = 75 (52.1%) male; mean age 24.8 (±2.9) years\] with varying levels of gambling severity. Participants were recruited through media advertising ("have you ever gambled?"), and had gambled at least five times during the past year. Also, 63 individuals (44.1%) were classified as recreational gamblers (see later for definitions), 47 (32.9%) as having subsyndromal GD, and 33 (23.1%) met criteria for GD.

Procedures {#S2b}
----------

All assessments were completed as a part of an ongoing study of gambling behavior in young adults. Participants were compensated with a US\$50 gift card to a local department store. Subjects were recruited in Chicago/IL and Minneapolis/MN metropolitan areas. Exclusion criteria included the inability to complete the study procedures, inability/unwillingness to provide voluntary written informed consent, and gambling frequency of less than five times in the past year. No medications were administered as a part of this study. Subjects taking medications were allowed to take part in the research.

Measurements {#S2c}
------------

### Demographics {#S2c1}

Age, gender, marital status, educational status, professional status, ethnicity, and sexual orientation were recorded.

### Severity of anxiety symptoms {#S2c2}

The Hamilton Anxiety Scale (HAM-A) is a valid and reliable instrument that assesses cross-sectional severity of anxiety symptoms ([@B27]; [@B40]; [@B63]). The HAM-A consists of 14 items (score range 0--56) that evaluate a variety of anxiety symptoms ([@B4]). HAM-A total score presents an intra-class coefficient of 0.74 and a concurrent validity between 0.63 and 0.75 ([@B40]). The HAM-A has shown good internal consistency (Cronbach's alpha = .893) ([@B36]). It is probably the most used and accepted scale to evaluate anxiety symptoms.

### Clinical variables {#S2c3}

1.  Gambling behavior: we evaluated the age at the start of regular gambling, the amount of money lost with gambling in the last year, and the average gambling frequency (times per week).

2.  Overall severity of GD: we assessed the total number of DSM-5 GD criteria using the Structured Clinical Interview for Gambling Disorder (SCI-PG) ([@B25]). SCI-PG was first validated using the criteria of the Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-4). Test--retest reliability on the number of GD criteria endorsed showed *r* = .97 (*p* = .006) ([@B25]). We retrospectively processed the electronic saved DSM-4 criteria for a proper adaptation to DSM-5. This procedure was performed deleting the criterion "committed illegal acts such as forgery, fraud, theft, or embezzlement to finance gambling regarding illegal acts," which was present in the previous manual, DSM-4. Moreover, we lowered the diagnostic threshold from five to four, consistent with DSM-5. Remaining criteria were unchanged. Severity was divided in three categories: recreational gambling (meets 0 DSM-5 criteria), subsyndromal GD (meets 1--3 DSM-5 criteria) and GD (meets 4 or more DSM-5 criteria).

    In addition, we investigated the overall gambling severity with the Pathological Gambling Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). It is a 10-item scale that showed high validity (*r* = .895) and reliability (Cronbach's α = .970) ([@B50]). This scale provides a total score (overall severity) as well as scores in two subscales (urges and behavior subscales).

3.  Impulsiveness: evaluated by the Barratt Impulsiveness Scale, version 11 (BIS-11) ([@B51]), a scale that has been largely used to investigate impulsiveness ([@B66]). This scale has shown good internal consistency (Cronbach's α between .79 and .83) ([@B51]). BIS-11 provides scores in three different dimensions, based on previous factor analyses: attentional impulsiveness, motor impulsiveness, and non-planning impulsiveness ([@B51]).

4.  Prevalence of illegal acts: the commitment of illegal acts to finance gambling activity has been associated with higher severity of GD ([@B21]; [@B67]; [@B68]). It was evaluated using an open question using previous DSM-4 criteria: "Have you committed illegal acts such as forgery, fraud, theft, or embezzlement to finance gambling?"

5.  Suicidality and psychiatric comorbidity: evaluated by the Mini-International Neuropsychiatric Interview (MINI) ([@B60]).

6.  Quality of life (quality of life inventory): a 17-item scale that evaluates the subject's overall quality of life ([@B18]). Alpha coefficients and test--retest correlations for this questionnaire have ranged, respectively, from 0.77 to 0.89 and from 0.80 to 0.91 ([@B43]).

7.  Use of nicotine: assessed by a 20-cigarette pack per day equivalent.

### Neurocognitive testing {#S2c4}

Individuals with GD tend to present with several neurocognitive deficits such as poorer response inhibition, low cognitive flexibility, worse decision making, and problems with sustained attention and executive functioning ([@B11]; [@B69]). This study evaluated whether anxiety symptoms affected any of these neuropsychological variables. In this context, participants undertook selected tests from the computerized Cambridge Neuropsychological Test Automated Battery (CANTABeclipse, version 3, Cambridge Cognition Ltd., Cambridge, UK) ([@B9]). Task order was fixed and the total duration of cognitive testing was approximately 50 min.

1.  Response inhibition: assessed by the stop-signal task, which assesses the subject's ability to inhibit/suppress motor responses. Individuals react to an arrow stimulus, by touching either a left or right key depending on the direction in which the arrow points. When an audio tone occurs, the participant attempts to suppress their motor response for the particular trial ([@B45]). The outcome measure of interest is the stop-signal reaction time, an index of the time taken for the person's brain to stop a response that would normally be made.

2.  Cognitive flexibility: investigated with the intra-dimensional/extra-dimensional set shifting test, which evaluates rule learning, reversal, and shifting of attentional focus across stimulus dimensions. The test uses visual stimuli (colorful shapes and white lines) and gives feedback to the individual so that they are able to learn an underlying "rule" about which stimulus is correct, based on trial and error. The underlining rule that determines what is "correct" and "incorrect" changes several times and assesses the individual's ability to respond with flexibility ([@B9]). The adjusted total number of errors is an overall score of performance.

3.  Decision making: assessed using the Cambridge Gamble Task, a test that assesses decision making and risk taking ([@B9]; [@B14]; [@B37]). The task simulates gambling activity but uses points for bets, rather than "real" rewards. The main outcome measures in this test are: quality of decision making, proportion of points gambled, and risk adjustment.

4.  Sustained attention: evaluated by the Rapid Visual Information Processing paradigm. This task investigates the ability to detect unpredictable target sequences over prolonged period of time ([@B56]). The task consists of a white box in the center of the computer screen, inside which numbers, from 2 to 9, show up in a pseudo-random manner, at the frequency of 100 digits/min. *A′* was used as a measure of sustained attention.

5.  Executive functioning: assessed using the One touch stockings of Cambridge task. This test, a variant of a variation of the Tower of London ([@B49]), investigates goal-directed planning ([@B9]). The task presents visual problems to the subject and evaluates the individual's ability to plan a solution and answer these problems.

Statistical analysis {#S2d}
--------------------

We analyzed the association between the severity of anxiety symptoms and demographic, clinical, and neurocognitive variables of the participants using Spearman's coefficients for continuous elements and Mann--Whitney tests for categorical variables.

To control for multiple comparisons, we divided the usual level of significance (*p* = .05) by the number of variables evaluated in each group of assessments (i.e., clinical variables and neurocognitive testing). Consequently, significance was defined as *p* ≤ .004 (.05/13 = .004) for clinical variables and *p* ≤ .007 (.05/7 = .007) for neurocognitive variables.

To reduce the likelihood of confounding variables contributing to the above analyses, we controlled for current major-depressive disorder, alcohol-use disorder, substance-use disorder, and nicotine use. These controls were included, as all four variables have demonstrated significant overlap with anxiety symptoms and several clinical/neurocognitive variables investigated in this study, in prior work ([@B11]; [@B40]).

Ethics {#S2e}
------

This research was approved by the Institutional Review Boards of the University of Chicago and the University of Minnesota. The study procedures were explained to the participants prior to providing consent, and all participants were given time to ask questions. All participants provided written informed consent.

Results {#S3}
=======

Table [1](#T1){ref-type="table"} describes the demographics and main clinical variables of our sample.

###### 

Description of demographics and main clinical variables of non-treatment-seeking gamblers (*n* = 143)

  Demographics                                            \% (*n*) or mean (*SD*)
  ------------------------------------------------------ -------------------------
  Age                                                           24.8 (±2.9)
  Gender                                                 
   Male                                                          52.4 (75)
   Female                                                        47.6 (68)
  Marital status                                         
   With partner                                                 79.7 (114)
   Without partner                                               20.3 (29)
  Educational status                                     
   Less than college                                             53.8 (77)
   College or more                                               46.2 (66)
  Occupational status                                    
   Studying or working                                          81.8 (117)
   Unemployed                                                    18.2 (26)
  Ethnicity                                              
   Caucasian                                                     43.3 (61)
   Non-Caucasian                                                 56.7 (80)
  Sexual orientation                                     
   Heterosexual                                                 83.9 (120)
   Other                                                         16.1 (23)
  Clinical variables                                     
   Anxiety symptoms severity  (Hamilton Anxiety Scale)          6.1 (±6.3)
   Age at the start of regular gambling                         18.9 (±3.0)
   Money lost with gambling (last year)                       2,221 (±4,325)
   Average gambling frequency  (times per week)                 2.9 (±2.9)
   Number of DSM-5 gambling  disorder criteria                  2.0 (±2.6)
   PG-YBOCS total score                                         7.9 (±8.1)

*Note.* *SD*, standard deviation; DSM-5, Diagnostic and Statistical Manual of Mental Disorders -- Fifth Edition; PG-YBOCS, gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale.

There was a significant positive correlation between the severity of anxiety symptoms and the number of current DSM-5 GD criteria. In addition, the quality of life was negatively correlated with the severity of anxiety symptoms. The presence of suicidality in gamblers was also associated with significantly higher scores on HAM-A, even after controlling for major depression, alcohol-use disorders, substance-use disorder, and use of nicotine (see also the findings using ANOVA, Figure [1](#fig1){ref-type="fig"}). The analysis also showed a direct correlation between anxiety symptoms in gamblers and higher scores on the attentional impulsivity dimension of BIS (i.e., higher attentional impulsiveness) (see Table [2](#T2){ref-type="table"}).

![Association between the severity of anxiety symptoms and the level of suicidality in non-treatment-seeking gamblers (*n* = 138). ^a^*p* value controlled for major depressive disorder, alcohol-use disorder, substance-use disorder, and smoking. ^b^The level of suicidality was defined by the MINI-score that accesses the risk of suicide in the past month. Suicidality is considered low (scores between 1 and 8 points), moderate (scores between 9 and 16 points), and high (scores ≥ 17)](jba-05-02-044_f001){#fig1}

###### 

Association between clinical variables and anxiety levels in non-treatment-seeking gamblers (*n* = 143)

  Clinical variables                             Spearman's correlation coefficient or mean HAM-A (*SD*)  *p* value[a](#T2-fn1){ref-type="table-fn"}   Adjusted correlation coefficient[b](#T2-fn2){ref-type="table-fn"} or effect size   Adjusted *p* value[b](#T2-fn2){ref-type="table-fn"}
  --------------------------------------------- --------------------------------------------------------- -------------------------------------------- ---------------------------------------------------------------------------------- -----------------------------------------------------
  Age started gambling regularly                                          −.170                           .043                                         −.135                                                                              .146
  Money lost with gambling (last year)                                    .222                            .008                                         .122                                                                               .186
  Average gambling frequency (times per week)                             .110                            .192                                         .048                                                                               .604
  Number of DSM-5 gambling disorder criteria                              .374                            \<.001                                       .363                                                                               \<.001
  PG-YBOCS total score                                                    .345                            \<.001                                       .213                                                                               .019
   PG-YBOCS urges subscale                                                .341                            \<.001                                       .183                                                                               .046
   PG-YBOCS gambling  behavior subscale                                   .307                            \<.001                                       .229                                                                               .012
  Barratt Impulsiveness Scale                                                                                                                                                                                                             
   Attentional                                                            .328                            \<.001                                       .290                                                                               .001
   Motor                                                                  .250                            .003                                         .198                                                                               .032
   Lack of planning                                                       .236                            .005                                         .088                                                                               .344
  Legal problems due to gambling (yes/no)                         2.5 (±2.1)/6.2 (±6.4)                   .437                                         −.036                                                                              .439
  Suicidality in the past month (yes/no)                         10.1 (±7.2)/4.5 (±5.2)                   \<.001                                       .040                                                                               \<.001
  Quality of life (quality of life inventory)                             −.343                           \<.001                                       −.292                                                                              .001

*Note.* HAM-A, Hamilton Anxiety Scale; *SD*, standard deviation; DSM-5, Diagnostic and Statistical Manual of Mental Disorders -- Fifth Edition; PG-YBOCS, gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale.

Significance was defined as *p* ≤ .004 (.05/13 = .004) for clinical variables.

Adjusted for current major-depressive, alcohol-use disorder, substance-use disorder, and nicotine use.

We did not find significant correlations between neurocognitive variables and anxiety symptoms (see Table [3](#T3){ref-type="table"}).

###### 

Association between neurocognitive variables and anxiety level in non-treatment-seeking gamblers (*n* = 143)

  Neurocognitive variables                                             Spearman's correlation coefficient   *p* value[a](#T3-fn1){ref-type="table-fn"}   Adjusted correlation coefficient[b](#T3-fn2){ref-type="table-fn"}   Adjusted *p* value[b](#T3-fn2){ref-type="table-fn"}
  -------------------------------------------------------------------- ------------------------------------ -------------------------------------------- ------------------------------------------------------------------- -----------------------------------------------------
  Response inhibition (delay at the stop-signal test)^c^               .051                                 .546                                         .047                                                                .617
  Decision making (Cambridge gamble task)                                                                                                                                                                                    
   Quality of decision making                                          −.093                                .273                                         −.109                                                               .243
   Overall proportion bet                                              .124                                 .141                                         .128                                                                .172
   Risk adjustment                                                     −.131                                .120                                         −.169                                                               .070
  Cognitive flexibility (intra--extra-dimensional set shifting test)   .170                                 .044                                         .158                                                                .091
  Sustained attention (rapid visual information processing)            −.235                                .005                                         −.153                                                               .101
  Executive functioning (one touch stockings of Cambridge)             −.209                                .014                                         −.102                                                               .274

Significance was defined as *p* ≤ .007 (.05/7 = .007) for neurocognitive variables.

Adjusted for current major-depressive, alcohol-use disorder, substance-use disorder, and nicotine use.

The following measures were used: \[delay at stop-signal test\] = stop-signal reaction time (ms); \[intra--extra dimensional set shifting test\] = total errors (adjusted); \[rapid visual information processing\] = proportion of targets detected; \[one touch stockings of Cambridge\] = problems solved in minimum possible number of moves.

Discussion and Conclusions {#S4}
==========================

This study analyzed the association of anxiety symptoms, gambling clinical variables, and neurocognitive variables in non-treatment-seeking gamblers. We evaluated subjects with a wide range of gambling severity (individuals who meet 0--9  DSM-5 GD criteria) and with different levels of anxiety (HAM-A scores from 0 to 28). The use of a non-treatment-seeking sample was important to achieve this spread of disease severities, to maximize the ability to detect the relationships between variables. Treatment-seeking gamblers tend to be more severe than gamblers in the general population ([@B53]) and therefore, the range of different levels of gambling activity is narrower in treatment-seeking samples. In addition, treatment-seeking gamblers may present a significant selection bias. Therefore, the use of a non-treatment-seeking sample enabled us to assess the association between anxiety, gambling, and neurocognition throughout a broad spectrum of gambling and anxiety levels.

This study found that the severity of anxiety symptoms was associated with several important clinical variables, even when controlling for major depression, alcohol-use disorder, substance-use disorder, and use of nicotine. There was a positive correlation between anxiety and gambling severities measured by the number of DSM-5 GD criteria met. There was also a positive correlation between anxiety severity and attentional impulsiveness. Participants with suicidality presented with higher levels of anxiety. Finally, the severity of anxiety symptoms was negatively correlated with the quality of life.

The number of DSM-5 criteria endorsed showed a positive correlation with anxiety levels. There was no significant correlation, however, between gambling severity, as measured by PG-YBOCS, and anxiety. The DSM-5 criteria assess the symptoms over the past year, whereas the PG-YBOCS was designed to evaluate severity during the past 7 days. Given that the anxiety is often a chronic condition; the DSM-5 criteria may more accurately capture the impact of these symptoms on gambling behavior.

A large epidemiological study suggested that anxiety disorders usually precede GD and appear to trigger gambling problems ([@B32]). The longitudinal relationship between anxiety symptoms and gambling activity, after gambling has started, remains unclear. In this context, important questions remain: do gamblers have a more harmful gambling activity due to higher anxiety levels? Or, does having severe gambling problems and, therefore more negative consequences, make gamblers feel more anxious? Future longitudinal studies should address this point.

The finding that anxiety levels were positively correlated with gambling severity is clinically important, and proper management of anxiety may improve treatment outcomes in gambling problems. Psychological therapies should address anxiety while identifying the reasons for gambling or for worsening of bets. Relaxation techniques and alternative ways to deal with anxiety (other than gambling) might be useful. Pharmacological approaches, such as the use of selective serotonin re-uptake inhibitors, may also enhance the control of anxiety. Grant and Potenza ([@B24]) found that the use of escitalopram in a sample of disordered gamblers with co-occurring anxiety significantly improved gambling and anxiety symptoms. Future clinical trials looking specifically at anxious gamblers are needed.

This study observed a positive correlation between attentional impulsiveness as indexed by the Barratt questionnaire, and severity of anxiety symptoms; and between worse sustained attention on a computerized task, and severity of anxiety symptoms. Attentional impulsiveness has been described as an inability to keep attention/concentration ([@B65]). When the BIS was first developed, attentional impulsiveness was believed to be an isolated dimension together with motor impulsiveness and lack of planning ([@B3]). Later research suggested that it is an underlying construct that interacts with motor impulsiveness and lack of planning ([@B51]). Therefore, attentional impulsiveness may be considered as a dimension that is correlated with impulsiveness in several levels ([@B51]).

Attentional bias is a well-characterized phenomenon in anxious individuals, who preferably allocate attention/focus on threatening stimuli rather than on neutral stimuli ([@B2]; [@B39]; [@B44]). This attentional bias to threat also leads to slower disengagement from threatening elements and, as a result of this, other non-threatening elements tend to be less perceived ([@B5]; [@B34], [@B35]; [@B57]). Therefore, an anxious individual who gambles may have a reduced focus on the gambling behavior (i.e., how to bet and how much to bet). Future studies might further investigate how the attentional bias interferes in gambling activity and could, particularly, look at possible threatening stimuli that are over-perceived during gambling behavior.

This study also observed that the severity of anxiety symptoms was positively associated with the presence of suicidality (Figure [1](#fig1){ref-type="fig"}).

This is an important finding for several reasons. First, suicide has a huge economic impact in the United States. For example, in 2010, the financial losses associated with suicide were estimated at 44 billion US dollars/year ([@B1]). Second, suicide is a top 2 leading cause of death in the United States for subjects aged 15--34 years ([@B10]), the population evaluated by this study. Third, GD and subsyndromal GD have been associated with higher rates of suicide ideation/attempts ([@B8]; [@B28]; [@B48]). Therefore, young gamblers appear to have a substantially elevated risk for suicide (age + gambling activity).

Unlike this research, the majority of previous studies that assessed suicide/risk of suicide in gamblers did not report a significant correlation between anxiety and suicidality. Two facts may explain this as follows: (a) some studies failed to assess the relationship between anxiety symptoms/anxiety disorders and suicide (see [@B28]) and (b) this study evaluated only young adults (aged 18--29 years), a group with higher anxiety symptoms, and higher suicidality ([@B10]; [@B42]). Therefore, anxiety symptoms may present a higher impact on suicidality in young gamblers and we evaluated a broad spectrum of gambling activity.

In fact, Grant et al. ([@B22]) used a subsyndromal GD sample and found an association between suicidality and anxiety disorders. However, the assessment of suicidality did not control for other mental disorders as this study did. As the correlation between GD and suicide ideation/attempts has been strongly attributed to co-occurring major depressive disorder and alcohol-/substance-use disorders ([@B12]; [@B28]), our study strengthens the possible separate association of anxiety symptoms and suicidality in gamblers.

A meta-analysis of 42 studies conducted by Kanwar et al. ([@B31]) suggested that anxiety disorders are associated with higher suicidality ([@B31]). Better assessment of anxiety symptoms, particularly in gamblers with suicidality seems to be important in clinical practice. As anxiety symptoms/disorders are considered relatively treatable ([@B29]), a more focused management in anxious gamblers may possibly reduce suicide risk.

Our study found that severity of anxiety was negatively correlated with the quality of life. This finding is consistent with previous epidemiological and clinical studies that have shown that anxiety disorders and subthreshold forms of anxiety disorders are associated with significantly reduced quality of life ([@B33]; [@B41]; [@B43]; [@B64]; [@B70]; [@B73]; [@B74]; [@B75]). On the other hand, subsyndromal GD and GD have also been associated with poorer life satisfaction when compared with the general population ([@B7]; [@B23]). Therefore, this study reinforces the negative correlation between anxiety and decreased quality of life in a non-treatment-seeking sample of impulsive patients.

Quality of life is a core dimension in psychiatry treatments and, as a result of this, this variable has been increasingly recognized as a main outcome measure in clinical trials ([@B26]; [@B30]; [@B54]; [@B64]; [@B72]). Anxiety may selectively affect some areas of quality of life. Spitzer et al. suggested that patients with anxiety disorders presented decreased scores particularly in role functioning. Further research should look at the effects of anxiety in specific dimensions. Cognitive-behavioral therapy focusing on training of social skills may benefit anxious gambling individuals.

This study should be interpreted in light of its limitations. First, this research used a cross-sectional analysis and, therefore, causal relationships cannot be confirmed. However, the analysis provides reliable measures of association. Second, some of the data collected (age at the start of recreational gambling and money lost with gambling in the last year) may be subject to potential recall bias, as it was collected in hindsight. Third, our sample consisted of a convenience sample of young adults (individuals aged 18--29 years). Therefore, caution is needed when generalizing our findings to broader segments of the population. Finally, our study used a low significance level \[i.e., .004 for (clinical variables) and .007 for (neurocognitive variables)\]. Therefore, we increased the likelihood of committing Type II error. On the other hand, we reduced the risk of finding false-positive results.

This study suggests that anxiety may be associated with relevant clinical variables in the broad spectrum of gambling activity. Therefore, proper management of anxiety symptoms might improve the clinical presentation of gamblers in different areas: (a) reducing the overall gambling severity; (b) improving the attentional deficits and attempting to reduce attentional impulsiveness; (c) reducing the risk/severity of suicidality; and (d) improving the quality of life.
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